Twist Bioscience Corp (TWST) — Strategic Asset Allocation Index
Twist Bioscience Corp (TWST) has a Strategic Asset Allocation Index of 15.0% as of March 2026. Strategic assets (PP&E of $- plus long-term investments of $68.09 Million) total $68.09 Million, measured against net assets of $455.09 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Twist Bioscience Corp Strategic Asset Allocation Index (2019–2025)
This chart shows how Twist Bioscience Corp's Strategic Asset Allocation Index has evolved across 6 annual periods from 2019 to 2025. As of March 2026, the index stands at 15.0%, representing strategic assets of $68.09 Million against net assets of $455.09 Million USD. Explore TWST cash flow metrics to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Twist Bioscience Corp (2019–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Twist Bioscience Corp from 2019 to 2025, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see TWST market cap.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 11.5% | $54.34 Million | $- | $54.34 Million | $472.96 Million | ▲ +11.2 pp |
| 2024 | 0.3% | $1.52 Million | $- | $1.52 Million | $472.69 Million | ▼ -26.8 pp |
| 2022 | 27.2% | $214.39 Million | $214.39 Million | $- | $789.38 Million | ▲ +19.6 pp |
| 2021 | 7.6% | $44.12 Million | $44.12 Million | $- | $580.82 Million | ▲ +0.0 pp |
| 2020 | 7.6% | $25.47 Million | $25.47 Million | $- | $336.26 Million | ▼ -6.1 pp |
| 2019 | 13.7% | $20.84 Million | $20.84 Million | $- | $152.08 Million | — |